March 31, 2021
PAR-21-208 - Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional)
National Institute on Drug Abuse (NIDA)
This Notice informs applicants of a changes to the Key Dates for Funding Opportunity Announcement (FOA) PAR-21-208, "Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional)".
The following Section of PAR-21-208 has been modified to reflect the changed dates:
Currently Reads:
Part 1. Overview Information
Key Dates
Application Due Dates |
Review and Award Cycles |
||||
New |
Renewal / Resubmission / Revision (as allowed) |
AIDS |
Scientific Merit Review |
Advisory Council Review |
Earliest Start Date |
August 10, 2021 |
August 10, 2021 |
August 10, 2021 |
November 2021 |
January 2022 |
April 2022 |
February 15, 2022 |
February 15, 2022 |
February 15, 2022 |
March 2022 |
May 2022 |
July 2022 |
August 10, 2022 |
August 10, 2022 |
August 10, 2022 |
November 2022 |
January 2023 |
April 2023 |
February 15, 2023 |
February 15, 2023 |
February 15, 2023 |
March 2023 |
May 2023 |
July 2023 |
August 10, 2023 |
August 10, 2023 |
August 10, 2023 |
November 2023 |
January 2024 |
April 2024 |
February 15, 2024 |
February 15, 2024 |
February 15, 2024 |
March 2024 |
May 2024 |
July 2024 |
Expiration Date:
February 16, 2024
Modified to Read (changes shown in bold italics):
Part 1. Overview Information
Key Dates
Application Due Dates |
Review and Award Cycles |
||||
New |
Renewal / Resubmission / Revision (as allowed) |
AIDS |
Scientific Merit Review |
Advisory Council Review |
Earliest Start Date |
August 10, 2021 |
August 10, 2021 |
August 10, 2021 |
November 2021 |
January 2022 |
April 2022 |
March 8, 2022 |
March 8, 2022 |
March 8, 2022 |
July 2022 |
October 2022 |
January 2022 |
August 10, 2022 |
August 10, 2022 |
August 10, 2022 |
November 2022 |
January 2023 |
April 2023 |
March 8, 2023 |
March 8, 2023 |
March 8, 2023 |
July 2023 |
October 2023 |
January 2023 |
August 10, 2023 |
August 10, 2023 |
August 10, 2023 |
November 2023 |
January 2024 |
April 2024 |
March 8, 2024 |
March 8, 2024 |
March 8, 2024 |
July 2024 |
October 2024 |
January 2024 |
Expiration Date:
March 9, 2024
All other aspects of this FOA remain the same.
Amy C. Lossie, PhD
National Institute on Drug Abuse (NIDA)
Telephone: 301-827-6092
Email: [email protected]